Showing results (1551-1560 of 2,791) with videos related to
Sort By:
Pageof 280
Cytotherapy|February 6, 2003
GM-CSF versus G-CSF: engraftment characteristics, resource utilization, and cost following autologous PBSC transplantationM S Zumberg, H L Leather, C Nejame, et al.Cytotherapy|February 6, 2003
Catastrophic failures of freezing bags for cellular therapy products: description, cause, and consequencesH M Khuu, H Cowley, V David-Ocampo, et al.Cytotherapy|August 27, 2002
Long-term follow-up of patients with CLL treated with allogeneic hematopoietic transplantationI F Khouri, M J Keating, R M Saliba, et al.Cytotherapy|August 27, 2002
Autologous and allogeneic transplantation for aggressive NHLS M Smith, D Grinblatt, K van BesienCytotherapy|August 27, 2002
Hematopoietic stem-cell transplantation for Hodgkin's disease (HD): current statusP AnderliniCytotherapy|August 27, 2002
In vitro interactions between gamma deltaT cells, DC, and CD4+ T cells; implications for the immunotherapy of leukemiaZ Ye, S Haley, A P Gee, et al.Cytotherapy|May 25, 2002
Tumor cell depletion of peripheral blood progenitor cells using positive and positive/negative selection in metastatic breast cancerR A Preti, H M Lazarus, J Winter, et al.Cytotherapy|June 4, 2002
Soluble adhesion molecules (sICAM-1, sL-Selectin, sE-Selectin, sCD44) in healthy allogenic peripheral stem-cell donors primed with recombinant G-CSFO Arslan, H Akan, M Arat, et al.Cytotherapy|June 4, 2002
In vitro generation of dendritic cells derived from cryopreserved CD34+ cells mobilized into peripheral blood in lymphoma patientsM Enomoto, H Nagayama, K Sato, et al.Cytotherapy|June 4, 2002
A new United States Pharmacopeia (USP) Chapter 1046: cell and gene therapy productsS SeaverPageof 280